Press Release Mar 17 2023

Published March 17, 2023 at 3:35 p.m. UTC

Unichem Laboratories Limited has informed the Exchange regarding a press release dated March 17, 2023, titled "Press release pertaining to the receipt of ANDA approval from the United States Food and Drug Administration (USFDA) for Unichem s Ranolazine Extended-Release Tablets, 500 mg, and 1000 mg.".

View Attachment

4:["$","main",null,{"className":"seo-shell seo-template-news","children":[["$","script",null,{"type":"application/ld+json","className":"seo-jsonld","dangerouslySetInnerHTML":{"__html":"{\"@context\":\"https://schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"Press Release Mar 17 2023\",\"description\":\"Unichem Laboratories Limited has informed the Exchange regarding a press release dated March 17, 2023, titled \\\"Press release pertaining to the receipt of ANDA approval from the United States Food and Drug Administration (USFDA) for Unichem s Ranolazine Extended-Release Tablets, 500 mg, and 1000 m...\",\"url\":\"https://6ix.com/news/press-release-mar-17-2023-8\",\"datePublished\":\"2023-03-17T15:35:41.000Z\",\"articleSection\":\"Business\",\"about\":{\"@type\":\"Corporation\",\"name\":\"Unichem Laboratories Limited\",\"url\":\"https://6ix.com/stock/nse-unichemlab/unichem-laboratories-limited\",\"tickerSymbol\":\"NSE:UNICHEMLAB\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"6ix\",\"url\":\"https://6ix.com\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https://6ix.com/images/social-banner.png?v=2\"}}}"}}],["$","div",null,{"className":"seo-page-frame","children":[null,[["$","style",null,{"dangerouslySetInnerHTML":{"__html":"$d"}}],["$","div",null,{"dangerouslySetInnerHTML":{"__html":"$e"}}]]]}]]}] 7:null